Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SLXP > SEC Filings for SLXP > Form 8-K on 22-Aug-2013All Recent SEC Filings

Show all filings for SALIX PHARMACEUTICALS LTD | Request a Trial to NEW EDGAR Online Pro

Form 8-K for SALIX PHARMACEUTICALS LTD


22-Aug-2013

Termination of a Material Definitive Agreement, Creation of a Direct Fi


Item 1.02. Termination of a Material Definitive Agreement.

Salix Pharmaceuticals, Ltd. (the "Company") has, pursuant to the Indenture, dated as of August 22, 2008, between the Company and the U.S. Bank National Association, as trustee (the "Trustee") governing the Company's 5.5% Convertible Senior Notes due 2028 (the "Notes"), notified the holders of the Notes on August 20, 2013 that the Company will redeem all outstanding Notes on September 23, 2013. The Notes will be redeemed at a price equal to 100% of the principal amount of the Notes, plus any accrued and unpaid interest.

As a result of the notice of redemption, holders are entitled, in lieu of having their Notes redeemed, to convert such Notes by surrendering them for conversion to the Trustee, in its capacity as Conversion Agent under the Indenture, no later than the close of business on September 20, 2013, and satisfying the other requirements set forth in the Notes and the Indenture. Upon any conversion, the Company shall deliver to the converting holders solely cash, solely shares of Common Stock, or a combination of cash and Common Stock, at its election. The Company plans to pay any converting holders cash for the face or par value of their notes and issue Common Stock of the Company for the remaining conversion value of the Notes. The total settlement amount the Company shall pay and deliver to each converting holder, in respect of each $1,000 principal amount of Notes being converted, will equal to the sum of the Daily Settlement Amounts for each of the forty consecutive Trading Days during the related Cash Settlement Averaging Period, each as defined in the Indenture. Based on current Common Stock trading prices, the Company expects the conversion value to be significantly more than the redemption price and, accordingly, the Company expects the holders to exercise their conversion rights.

Upon conversion and/or redemption of all of the Notes, the Company intends to terminate the Indenture.



Item 2.03. Creation of a Direct Financial Obligation under an Off-balance Sheet Arrangement.

The information set forth in Item 1.02 is incorporated herein by reference.



Item 8.01. Other Events.

On August 20, 2013, the Company issued a press release relating to the redemption set forth in Item 1.02 above. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit
No. Description

99.1 Press release dated August 20, 2013 (filed pursuant to item 8.01).


  Add SLXP to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SLXP - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.